NEW: Ping your patients with TxtSquad
Published June 23, 2023
Here's another exclusive benefit for our PFMs...
APC News
25 members of Congress send hormone letter to FDA
Published June 23, 2023
Twenty-five members of Congress signed a joint letter that was sent this week to FDA urging that the agency protect compounded hormone therapy.
Nevada authorizes 503Bs to sell compounded drugs to 503As
Published June 23, 2023
Nevada SB 161 has been signed into law by the governor and contains provisions that affect 503B outsourcing facilities...
APC advises BOPs on USP <797> restrictions
Published June 23, 2023
This week, APC sent an advisory memo to state boards of pharmacy raising concerns about adopting without careful consideration the new USP Chapter <797> restrictions on beyond-use dates and batch sizes.
Weigh in on drug shortages via RFI
Published June 23, 2023
House Energy & Commerce Committee Chair Cathy McMorris Rodgers (WA) and Senate Finance Committee Chair Mike Crapo (ID) have issued a joint request for information regarding the country's drug shortages...
Nevada legislature reverses state’s BOP mandate
Published June 16, 2023
The Nevada Legislature recently reversed a previous interpretation by the state's Board of Pharmacy that mandated out-of-state pharmacists to obtain a Nevada pharmacist license when dispensing or compounding prescriptions.
FDA: Know your bulks and excipients suppliers
Published June 16, 2023
Earlier this week, FDA issued a new guidance to compounders, Know Your Bulks and Excipients Suppliers.
CCH registration is NOW OPEN
Published June 15, 2023
Registration for APC’s annual DC fly-in, Compounders on Capitol Hill, opened today. Act now to take advantage of our discounted early-bird registration—including extra-special pricing for our PFM members.
Topi-CLICK bumps up!
Published June 9, 2023
APC corporate supporter Topi-CLICK has recently increased its support for APC, moving from a $10,000 investment to an annual $25,000 investment.
A welcome clarification on veterinary bulk substances
Published June 9, 2023
This week in a communication with an APC member pharmacy, FDA’s Center for Veterinary Medicine made some clarifications.
Couple of quick state updates
Published June 9, 2023
APC and NCPA have sent a joint letter to the Oregon Board of Pharmacy expressing concern about the agency’s recent fiscal impact request regarding proposed rules on pharmacist licensure and counseling requirements.
Congressional letter deadline is today
Published June 9, 2023
Today is the last day for members of Congress to add their names to a joint letter to FDA in support of maintaining access to compounded hormones. The letter is led by Rep. Jennifer Wexton (D-VA).
CCH early bird registration opens June 15
Published June 9, 2023
Attendee registration opens June 15 for APC’s annual DC fly-in, Compounders on Capitol Hill.
FDA issues public statement on compounded semaglutide
Published June 2, 2023
Earlier this week, FDA issued its first public statement on semaglutide compounding. The statement elaborates on what the agency said in its April letter to NABP on the subject.
Call to Action on Urgent Use: Have you responded?
Published June 2, 2023
Send a message to your respective members of Congress, asking them to support legislative language that will allow pharmacy compounders to help fill urgent gaps in the drug supply chain.
Compounding Compliance Conference: APC members get a discount
Published June 2, 2023
APC members are invited to attend Informa Connect’s two-day program, Compounding Pharmacy Compliance at a special, members-only rate (use code 23A4PC15 to receive 15 percent off your registration fee).
FDA hears from APC leaders
Published May 26, 2023
Earlier this week, APC’s Executive Committee and Federal Legislative Committee leaders met virtually with FDA’s Office of Compounding Quality + Compliance team to discuss a range of issues impacting pharmacy compounding.
Show ‘em your briefs!
Published May 26, 2023
APC and the Pharmacy Compounding Foundation offer a series of briefing papers to help you educate prescribers about a range of pharmacy compounding topics.
Tennessee expands State BOP
Published May 26, 2023
Tennessee Governor Bill Lee has approved Senate Bill 753, which expands the state’s Board of Pharmacy from seven members to nine members and creating designated seats for a pharmacy technician and a consumer member.
There’s still time: Call to action on Urgent Use
Published May 24, 2023
We’re asking our members and supporters to send a message to your member of Congress, urging your elected officials to support legislative language enabling pharmacy compounders to help fill urgent gaps in the drug supply chain.
Moser elected 2024 APC vice president
Published May 19, 2023
At its meeting this week in Alexandria, the APC Board of Directors unanimously elected Michelle Moser, Revelation Pharma/Makers Compounding Pharmacy, Mount Vernon, WA as Board Vice President for 2024.
ACT Conference notches 130+ Hill visits
Published May 19, 2023
PCCA hosted its ACT Conference in Washington, DC, this week, with more than 80 compounders attending and more than 130 Hill visits conducted. Here’s a photo composite recapping just a few of those.
APC issues statement on shortage-drug compounding and semaglutide
Published May 19, 2023
Earlier this week, APC released an extensive statement on compounding copies of FDA approved drugs when those drugs are in shortage. The statement focuses in particular on semaglutide.
Sport your APC pride with updated logos
Published May 19, 2023
In the spirit of embracing the joy we feel as pharmacy compounders, the APC logo was recently refreshed to include our new “Compounding the Joy” tagline.
Medisca will match investments in ‘Compounding Joy’ campaign
Published May 12, 2023
Medisca is supporting APC's “Compounding the Joy of Living” campaign by matching all individual contributions, dollar for dollar, up to $100,000.
New Prescriber Brief: Compounding for racehorses
Published May 12, 2023
The latest in APC’s suite of briefing documents for prescribers is available and it summarizes regulation governing the use of compounded medications for racehorses.
Tennessee BOP heeds APC’s recommendations
Published May 12, 2023
Heeding APC's recommendations, the Board voted at its May 8 hearing to strike this language from the rules, removing this potentially burdensome change.
Califf positive on permanent urgent-use compounding fix
Published May 12, 2023
FDA Commissioner Dr. Robert Califf recently acknowledged the importance of compounding for addressing drug shortages during emergencies.
Interested in patient-reported outcomes? Join our user group
Published May 5, 2023
Compounding pharmacies using OutcomeMD, a patient-reported outcomes (PROs) tool, can now join our user group. As an APC member, you can access this tool at a special members-only subscription rate.
Free patient testimonial videos: Play ‘em in your waiting area
Published May 5, 2023
Showcasing patient testimonials in your compounding pharmacy's waiting area can have a significant impact on building trust with your patients and improving their experience.
